HRSA FY2025 audits showed 49% adverse findings, driven mainly by administrative inaccuracies; incorrect OPAIS records appeared in 75% of adverse audits, underscoring persistent master-data governance ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

While audits are part of doing business in the ordinary course, businesses are generally less than eager to open the books. And the same is true when it comes to the 340B Drug Pricing Program. Audits ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

Mercy Medical Center, a 262-bed nonprofit, university-affiliated teaching hospital based in Baltimore, has long relied on its 340B Drug Pricing Program as a critical funding mechanism for charitable ...